Cowen Inc’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
– Sell
-177,700
Closed -$675K – 294
2016
Q2
$675K Sell
177,700
-500
-0.3% -$1.7K 0.04% 145
2016
Q1
$492K Sell
178,200
-38,410
-18% -$139K 0.02% 177
2015
Q4
$938K Buy
216,610
+25,210
+13% +$154K 0.07% 154
2015
Q3
$1.01M Sell
191,400
-38,100
-17% -$295K 0.06% 146
2015
Q2
$1.7M Buy
229,500
+49,500
+28% +$240K 0.1% 123
2015
Q1
$832K Hold
180,000
– – 0.07% 149
2014
Q4
$549K Hold
180,000
– – 0.04% 150
2014
Q3
$501K Buy
+180,000
New +$653K 0.05% 186

Other funds holding SGYP

Cowen Inc's SGYP Position: Q3 2016 in Review

Cowen Inc sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q3 2016, closing a stake of 177,700 shares — an estimated $675K sold.

Cowen Inc first reported a position in SGYP in Q3 2014 and held it in 8 quarters. The position peaked at $1.7M in Q2 2015. 149 funds tracked by Wall St. Rank hold SGYP as of Q3 2016.

  • Cowen Inc reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q3 2016 after selling out during the quarter.
  • Cowen Inc sold 177,700 Synergy Pharmaceuticals, Inc Common Stock shares in Q3 2016, an estimated $675K.
  • Cowen Inc first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2014 and held it in 8 quarters.
  • Cowen Inc's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.7M in Q2 2015.
  • 149 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q3 2016.

Based on Cowen Inc's 13F filing for Q3 2016, filed 14 Nov 2016.